Legis Daily

Faster Treatments and Cures for Eye Diseases Act

USA116th CongressHR-2620| House 
| Updated: 5/10/2019
Sanford D. Bishop

Sanford D. Bishop

Democratic Representative

Georgia

Cosponsors (21)
Tom O'Halleran (Democratic)Jared Huffman (Democratic)Pete Olson (Republican)Darren Soto (Democratic)Eliot L. Engel (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tim Walberg (Republican)Kenny Marchant (Republican)Gus M. Bilirakis (Republican)Henry C. "Hank" Johnson (Democratic)G. K. Butterfield (Democratic)Gregory W. Meeks (Democratic)John H. Rutherford (Republican)Jeff Fortenberry (Republican)Brian K. Fitzpatrick (Republican)Bradley Scott Schneider (Democratic)Cathy McMorris Rodgers (Republican)Debbie Wasserman Schultz (Democratic)Mike Levin (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Faster Treatments and Cures for Eye Diseases Act This bill requires the Department of Health and Human Services to establish a pilot program that provides for a partial federal guarantee of specified bonds, the sale of which shall finance promising translational vision-impairment research with private investment. The Government Accountability Office must study this program and consider whether similar programs should be established for other areas of biomedical research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 9, 2019
Introduced in House
May 9, 2019
Referred to the House Committee on Energy and Commerce.
May 10, 2019
Referred to the Subcommittee on Health.
  • May 9, 2019
    Introduced in House


  • May 9, 2019
    Referred to the House Committee on Energy and Commerce.


  • May 10, 2019
    Referred to the Subcommittee on Health.

Health

Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug therapyExecutive agency funding and structureFinancial services and investmentsGeneticsGovernment information and archivesGovernment lending and loan guaranteesGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHearing, speech, and vision careInterest, dividends, interest ratesMedical researchPublic-private cooperationResearch administration and fundingResearch and developmentSecuritiesUser charges and fees

Faster Treatments and Cures for Eye Diseases Act

USA116th CongressHR-2620| House 
| Updated: 5/10/2019
Faster Treatments and Cures for Eye Diseases Act This bill requires the Department of Health and Human Services to establish a pilot program that provides for a partial federal guarantee of specified bonds, the sale of which shall finance promising translational vision-impairment research with private investment. The Government Accountability Office must study this program and consider whether similar programs should be established for other areas of biomedical research.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 9, 2019
Introduced in House
May 9, 2019
Referred to the House Committee on Energy and Commerce.
May 10, 2019
Referred to the Subcommittee on Health.
  • May 9, 2019
    Introduced in House


  • May 9, 2019
    Referred to the House Committee on Energy and Commerce.


  • May 10, 2019
    Referred to the Subcommittee on Health.
Sanford D. Bishop

Sanford D. Bishop

Democratic Representative

Georgia

Cosponsors (21)
Tom O'Halleran (Democratic)Jared Huffman (Democratic)Pete Olson (Republican)Darren Soto (Democratic)Eliot L. Engel (Democratic)Terri A. Sewell (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tim Walberg (Republican)Kenny Marchant (Republican)Gus M. Bilirakis (Republican)Henry C. "Hank" Johnson (Democratic)G. K. Butterfield (Democratic)Gregory W. Meeks (Democratic)John H. Rutherford (Republican)Jeff Fortenberry (Republican)Brian K. Fitzpatrick (Republican)Bradley Scott Schneider (Democratic)Cathy McMorris Rodgers (Republican)Debbie Wasserman Schultz (Democratic)Mike Levin (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug therapyExecutive agency funding and structureFinancial services and investmentsGeneticsGovernment information and archivesGovernment lending and loan guaranteesGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHearing, speech, and vision careInterest, dividends, interest ratesMedical researchPublic-private cooperationResearch administration and fundingResearch and developmentSecuritiesUser charges and fees